Literature DB >> 2552145

Evidence for interference, coinfections, and intertypic virus enhancement of infection by ovine-caprine lentiviruses.

P E Jolly1, O Narayan.   

Abstract

The ovine-caprine lentiviruses share nucleotide homology and serological properties in their gag-pol genes and gene products but constitute two distinct biological groups represented by ovine visna virus of Icelandic origin and by caprine arthritis-encephalitis and ovine progressive pneumonia viruses of U.S. origin. Two members of each group, visna 1514 and its antigenic variant LV1-1 in the first group and CAEV/CO and S93, a field isolate virus from a local arthritic sheep, in the second group, were examined in the present study in competitive-binding studies in fibroblast and macrophage cell cultures. The cultures were preinoculated with each of the four viruses and then reinoculated with either 1514 virus or CAEV/CO, labeled with [35S]methionine. Both 1514 and CAEV/CO caused homologous interference. LV1-1 and S93 viruses shared the interference patterns of 1514 and CAEV/CO, respectively. 1514 and LV1-1 did not interfere with binding of CAEV/CO. Similarly, CAEV/CO and S93 did not interfere with binding of 1514. Remarkably, certain combinations, such as S93 plus 1514, resulted in enhanced binding of the second virus. Other experiments showed that the enhancement in binding extended to enhancement in replication of the second virus. These latter data suggested that individual cells supported replication of both viruses. Further testing of this phenomenon showed that goats could be doubly infected with two noninterfering viruses, 1514 and CAEV/CO. The ability of noninterfering related lentiviruses to infect the same cell and also the same host animal may be important in the natural history of these viruses in providing ideal conditions for the development of new recombinant viruses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552145      PMCID: PMC251103          DOI: 10.1128/JVI.63.11.4682-4688.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Visna, a demyelinating transmissible disease of sheep.

Authors:  B SIGURDSSON; P PALSSON; H GRIMSSON
Journal:  J Neuropathol Exp Neurol       Date:  1957-07       Impact factor: 3.685

2.  The synthesis and structure of visna virus DNA.

Authors:  J E Clements; O Narayan; D E Griffin; R T Johnson
Journal:  Virology       Date:  1979-03       Impact factor: 3.616

3.  Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies.

Authors:  G Pétursson; N Nathanson; G Georgsson; H Panitch; P A Pálsson
Journal:  Lab Invest       Date:  1976-10       Impact factor: 5.662

4.  Virus mutation during 'slow infection': temporal development and characterization of mutants of visna virus recovered from sheep.

Authors:  O Narayan; D E Griffin; J E Clements
Journal:  J Gen Virol       Date:  1978-11       Impact factor: 3.891

5.  The structural polypeptides of RNA slow viruses.

Authors:  A T Haase; J R Baringer
Journal:  Virology       Date:  1974-01       Impact factor: 3.616

6.  Patterns of viral interference in the avian leukosis and sarcoma complex.

Authors:  P K Vogt; R Ishizaki
Journal:  Virology       Date:  1966-11       Impact factor: 3.616

7.  Infectious leukoencephalomyelitis of young goats.

Authors:  L C Cork; W J Hadlow; T B Crawford; J R Gorham; R C Piper
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

8.  Antigenic variation in visna virus.

Authors:  J V Scott; L Stowring; A T Haase; O Narayan; R Vigne
Journal:  Cell       Date:  1979-10       Impact factor: 41.582

9.  Chronic arthritis in goats caused by a retrovirus.

Authors:  T B Crawford; D S Adams; W P Cheevers; L C Cork
Journal:  Science       Date:  1980-02-29       Impact factor: 47.728

10.  Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures.

Authors:  J W Hartley; W P Rowe; R J Huebner
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

View more
  8 in total

1.  Simultaneous detection of infectious human echoviruses and adenoviruses by an in situ nuclease-resistant molecular beacon-based assay.

Authors:  Daniela Dunams; Payal Sarkar; Wilfred Chen; Marylynn V Yates
Journal:  Appl Environ Microbiol       Date:  2011-12-22       Impact factor: 4.792

2.  Host range of small-ruminant lentivirus cytopathic variants determined with a selectable caprine arthritis- encephalitis virus pseudotype system.

Authors:  I Hötzel; W P Cheevers
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Domain Organization of Lentiviral and Betaretroviral Surface Envelope Glycoproteins Modeled with AlphaFold.

Authors:  Isidro Hötzel
Journal:  J Virol       Date:  2021-10-27       Impact factor: 6.549

4.  Identification of cell membrane proteins that bind visna virus.

Authors:  S E Crane; J Buzy; J E Clements
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Demonstration of coinfection with and recombination by caprine arthritis-encephalitis virus and maedi-visna virus in naturally infected goats.

Authors:  Giuliano Pisoni; Giuseppe Bertoni; Maria Puricelli; Marina Maccalli; Paolo Moroni
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

6.  Genomic Epidemiology and Heterogeneity of SRLV in Italy from 1998 to 2019.

Authors:  Moira Bazzucchi; Ilaria Pierini; Paola Gobbi; Silvia Pirani; Claudia Torresi; Carmen Iscaro; Francesco Feliziani; Monica Giammarioli
Journal:  Viruses       Date:  2021-11-23       Impact factor: 5.048

Review 7.  Small ruminant lentiviruses: genetic variability, tropism and diagnosis.

Authors:  Hugo Ramírez; Ramsés Reina; Beatriz Amorena; Damián de Andrés; Humberto A Martínez
Journal:  Viruses       Date:  2013-04-23       Impact factor: 5.048

8.  Virus-virus interactions and host ecology are associated with RNA virome structure in wild birds.

Authors:  Michelle Wille; John-Sebastian Eden; Mang Shi; Marcel Klaassen; Aeron C Hurt; Edward C Holmes
Journal:  Mol Ecol       Date:  2018-11-22       Impact factor: 6.185

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.